Quote:

---

The alternative, bleaker explanation, which the shorts are putting forth, doesn't make sense. If Cytodyn was facing its own End Times, it wouldn't be making hires, seeking a CEO, continuing trials, and sitting on results we're all pretty damn sure are excellent.

---

Those are straight out fools....more than likely, "The Team" showed Samsung enough data or made them aware of potential partners to forestall the payment for a period of time....was this because Samsung believes they will be producing a lot more Leronlimab only or are they "kicking the tires and checking under the hood" prior to making a deal for partnership or buyout?

Why in hell would we file BK with 200M unsold shares (even at the current low sp). Unless or until we are told differently, I am waiting on news of partnership/possible buyout and adding shares as I can.